effect of short term pulmonary rehabilitation among pulmonary tuberculosis patients during covid-19 pandemic

Not yet recruiting

Conditions: Respiratory disorder, unspecified,

Registration Number: CTRI/2022/03/041223

Lead Sponsor: Munazzah Orooj

Brief Summary: **Objective***:* To investigate the effect of short-term Pulmonary Rehabilitation program (PR) among Pulmonary tuberculosis patients during pandemic.

**Methods:**Twenty-eight patients will be randomly allocated to the PR group, which comprised of supervised endurance training, resistance training, breathing exercises, self-management, and education. The other 28 patients will be allocated to the control group, who will be asked to continue their usual routine strategies for four weeks. All measurements will be made at enrolment and after completion of 4 weeks of Pulmonary Rehabilitation using the six-minute walk test (6MWT), Modified**Medical Research Council**(Mmrc) Dyspnea Scale, pulmonary function test (PFT), and SF-36.

Detailed Description: Not available

Recruitment & Eligibility

Status: Not Yet Recruiting

Sex: All

Target Recruitment: 56

Inclusion Criteria

Inclusion criteria includes all patients with pulmonary tuberculosis 18 years of age and older, exhibit shortness of breath on exertion, have limitations in the activity of daily living and patients who have completed their chemotherapy.

Exclusion Criteria

Exclusion criteria include all the contraindications of pulmonary rehabilitation such as a history of myocardial infarction, angina, and congestive heart failure.
An older patient with age above 80 years and patients with orthopedic or cognitive impairment that would interfere with the regular participation in the rehabilitation program.
Those who are unwilling or unable to attend the PR program.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
PULMONARY REHABILITATION	4 weeks
Aerobic training (Walking)resistance training and education will be provided and Quality of life along with lung function and exercise tolerance will be checked at baseline and after 4 weeks	4 weeks

Secondary Outcome Measures

Name	Time	Method
PULMONARY FUNCTION TEST	SGRQ

Trial Locations

Locations (1): Sharda Hospital
🇮🇳
Nagar, UTTAR PRADESH, India
Sharda Hospital
🇮🇳Nagar, UTTAR PRADESH, India
Munazzah Orooj
Principal investigator
8744873780
munazzaorooj999@gmail.com